Copyright
©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 532-542
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532
Table 7 Comparison of incidence of adverse reaction between the two groups, n (%)
| Groups | Bulbar conjunctival hemorrhage | Too high intraocular pressure | Adverse reaction |
| Compaq group (n = 48) | 2 | 1 | 3 (6.25) |
| Ranibizumab group (n = 48) | 4 | 2 | 6 (12.50) |
| χ2 value | 1.333 | ||
| P value | 0.248 |
- Citation: Li YF, Ren Q, Sun CH, Li L, Lian HD, Sun RX, Su X, Yu H. Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients. World J Diabetes 2022; 13(7): 532-542
- URL: https://www.wjgnet.com/1948-9358/full/v13/i7/532.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i7.532